查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442910

免疫测定 - 全球市场考量、竞争格局和市场预测 (2030)

Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2024-2030年预测期内，全球免疫分析市场规模将以7.53%的复合年增长率大幅成长。免疫分析的需求主要是由癌症等慢性疾病和糖尿病等生活方式疾病的日益普及所推动的。乳癌和摄护腺癌等各种肿瘤疾病的增加是影响市场积极成长的主要因素。此外，人们对疾病早期诊断的认识不断提高也有助于免疫分析市场在 2024-2030 年预测期内的整体成长。

免疫分析市场动态

根据International Diabetes Federation (IDF) (2021) 的数据，2021 年全球约有 5.37 亿 20 至 79 岁的成年人患有糖尿病。根据相同数据，到 2030 年，全球约有 6.43 亿人将受到糖尿病的影响。使用免疫分析可以准确检测与糖尿病相关的各种生物标记物，例如胰岛素和C肽。因此，糖尿病盛行率的增加增加了对免疫测定的需求并有助于市场成长。

根据世界卫生组织 (WHO) (2022) 的数据，2020 年全球报告了约 226 万例乳癌病例、221 万例肺癌病例和 193 万例大肠直肠癌病例。因此，肺癌、乳癌和摄护腺癌等成人癌症病例数量的不断增加，以及医生建议每年对这些疾病进行生物标记检测，正在推动免疫分析市场的发展，这就是前景。

此外，HIV、肝炎等传染病发生率的上升也是免疫分析市场的主要驱动因素之一。根据世界卫生组织 (WHO) (2022) 的数据，预计 2022 年全球约有 3.54 亿人感染乙型或C型肝炎。因此，传染病患者数量的增加将进一步增加对诊断的需求并有助于市场成长。

然而，与免疫检测试剂盒和仪器相关的技术问题、高成本以及缺乏执行这些复杂测试所需的熟练专业人员可能会限制免疫检测市场的成长，并成为一个障碍。

免疫分析市场细分分析

在免疫分析市场的产品领域，试剂和试剂盒类别预计将在 2023 年获得可观的收入占有率。这是由于世界各地慢性病和传染病的增加以及免疫测定测试数量的增加，对免疫测定试剂盒和试剂的需求和消耗量很高。此外，免疫检测试剂盒所提供的各种优势，例如高灵敏度和强特异性也是促进此细分市场成长的因素之一。

此外，每次测试都需要试剂盒和试剂，使它们成为测试过程中不可或缺的一部分。

此外，随着这一领域的需求不断增加，许多新产品正在引入市场。2021 年 2 月，Agilent Technologies推出了 Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay（ELISA），用于检测人类血清或血浆中针对 SARS-CoV-2 的免疫球蛋白 G (IgG) 抗体。

因此，由于上述因素，预计试剂和试剂盒类别将显着成长，推动整个免疫分析市场在预测期内的成长。

预计北美将主导整个免疫分析市场。

在所有地区中，预计到 2023 年北美将占免疫分析市场的最大占有率。这被认为是由于该地区存在不健康的生活习惯，以及大量患有糖尿病、甲状腺疾病等各种生活方式相关疾病的患者。此外，消费者对疾病诊断的高度认识、政府支持以及产品开发和上市的优势也是影响该地区市场成长的因素。

本报告提供了全球免疫分析市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章 免疫分析市场报告简介

第二章免疫分析市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章免疫分析市场关键因素分析

  • 免疫分析市场驱动因素
  • 免疫分析市场的限制与挑战
  • 免疫分析市场机会

第五章免疫分析市场的波特五力分析

第六章 免疫检测市场布局

  • 依产品
    • 试剂/试剂盒
    • 用具
  • 依技术
    • 放射免疫分析
    • 酵素连结免疫分析
    • 萤光免疫分析
    • 化学发光免疫分析
    • 其他
  • 依用途
    • 传染病测试
    • 心
    • 肿瘤
    • 内分泌
    • 自身免疫性疾病
  • 依标本分类
    • 血
    • 尿
    • 唾液
  • 依最终用户
    • 医院/诊所
    • 诊断实验室
    • 製药和生物技术产业
  • 区域
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第 7 章. 免疫分析市场公司与产品概况

  • Beckman Coulter, Inc.
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Autobio
  • PHC Corporation
  • Trivitron Healthcare
  • Werfen
  • Danaher Corporation
  • Sysmex Corporation
  • ALPCO
  • Quidel Corporation
  • ZECEN Biotech Co. Ltd.
  • Awareness Technology
  • Diatron
  • Macscura Biotechnology Co.
  • Guangzhou Jinde Biotech Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Medcaptain Medical Technology Co., Ltd.

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明，联络我们

Product Code: DIMDCL0696

Immunoassay Market By Product (Reagents & Kits And Instruments), Technology (Radioimmunoassay, Enzyme-Linked Immunoassay, Chemiluminescence Immunoassay, Fluoroimmunoassay, And Others), Sample (Blood, Urine, Saliva, And Others), Application (Oncology, Cardiology, Infectious Disease Testing, Endocrinology, Autoimmune Disorders, And Others), End-User (Hospitals & Clinics, Diagnostic Labs, Pharmaceuticals & Biotech Industries, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, lifestyle diseases such as diabetes mellitus, and others, and the growing prevalence of infectious diseases such as hepatitis, hiv, and others

The global Immunoassay market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period from 2024 to 2030. The demand for immunoassay is primarily being boosted by the increasing prevalence of chronic disorders such as cancers, and lifestyle disorders such as diabetes mellitus, among others. The increase in various oncological disorders such as breast cancer and prostate cancer is a key factor influencing the positive growth of the market. Further, the rising awareness among people regarding early disease diagnosis is also contributing to the overall growth of the immunoassay market during the forecast period from 2024-2030.

Immunoassay Market Dynamics:

As per the International Diabetes Federation (IDF) 2021, worldwide around 537 million adults aged between 20 and 79 years had diabetes in the year 2021. Also, according to the same source around 643 million people will be suffering from diabetes by 2030, globally. The various biomarkers associated with diabetes mellitus such as insulin and C-peptide can be detected accurately with immunoassay. Thus, the rising prevalence of diabetes will increase the demand for immunoassay, thereby contributing to its market growth.

As per the World Health Organization (WHO) 2022, there were around 2.26 million cases of breast cancer, 2.21 million cases of lung cancer, and 1.93 million cases of colon and rectal cancer, reported in the year 2020 globally. Therefore, the rising cases of cancers such as lung, breast, and prostate cancer amongst the adult population as well as the recommendation of annual tests for biomarkers of these diseases by doctors is going to accelerate the market for immunoassay.

Further, the rising cases of infectious disorders such as HIV, hepatitis, and others is another key driver for the immunoassay market, as immunoassays are widely used for the diagnosis of infectious disorders. According to the World Health Organization (WHO) 2022, it was estimated that in 2022, around 354 million people were living with Hepatitis B or C infections, globally. Therefore, the increasing cases of infectious diseases will further increase the demand for diagnosis, thus contributing to market growth.

However, technical issues associated with the immunoassay test kits and instruments, high costs, along with the lack of skilled professionals required to perform these complicated tests are some of the market barriers that may restrict the growth of the immunoassay market.

Immunoassay Market Segment Analysis:

Immunoassay Market by Product (Reagents & Kits and Instruments), Technology (Radioimmunoassay, Enzyme-Linked Immunoassay, Chemiluminescence Immunoassay, Fluoroimmunoassay, and Others), Sample (Blood, Urine, Saliva, and Others), Application (Oncology, Cardiology, Infectious Disease Testing, Endocrinology, Autoimmune Disorders, and Others), End-User (Hospitals & Clinics, Diagnostic Labs, Pharmaceuticals & Biotech Industries, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Immunoassay market, the reagents & kits category is expected to amass a significant revenue share in the year 2023. This can be attributed to the high demand and consumption of immunoassay kits and reagents and the increasing number of immunoassay tests performed, due to the increasing number of chronic and infectious disorders around the globe. Additionally, various advantages provided by immunoassay kits such as high sensitivity and strong specificity are also some of the factors contributing to the growth of the segment.

Further, the kits and reagents are required for every test making them an integral part of the testing process.

Furthermore, with the growing demand for this segment, numerous new products are being launched in the market. In February 2021, Agilent Technologies launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, which is used for the detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

Therefore, owing to the above-mentioned factors, the reagents & kits category is expected to register significant growth, thereby driving the growth of the overall Immunoassay market during the forecast period.

North America is expected to dominate the overall Immunoassay Market:

Among all the regions, North America is estimated to account for the largest share of the Immunoassay market in the year 2023. This can be attributed to the presence of unhealthy lifestyles in the region contributing to a large patient pool suffering from various lifestyle disorders such as diabetes mellitus and thyroid diseases. Additionally, high consumer awareness regarding disease diagnosis, government support, and a dominant market in terms of product development and launches are among other factors influencing the growth of the market in the region.

One of the prominent factors supporting the growth of the North America immunoassay market is the extensive use of immunoassay in the detection of tumor markers indicating cancer development. For instance, according to National Cancer Institute 2020, it was estimated that around 1,806,590 cancer cases were diagnosed in the year 2020 in the United States. Additionally, as per the same source prostate, lung, and colorectal cancer accounted for 43% of the cancer cases in men, and breast, lung, and colorectal making up to 50% of cancer cases in women.

Further, according to the data provided by The Government of Canada 2021, cancer is one of the leading causes of death in Canada. In 2021, around 229,200 Canadians were diagnosed with cancer and 84,600 people died from cancer in Canada. This indicates the huge need for early detection of the diseases, therefore leading to the growth of immunoassay market in the region.

Moreover, the rise in chronic and cardiovascular diseases such as coronary artery diseases, and stroke among the US population is another driver of the immunoassay market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, around 18.2 million people aged 20 or above had coronary artery disease in the United States. Also, as per the same source around 805,000 people face heart attacks every year in the United States. This indicates the huge need for immunoassay for the detection of cardiac markers assisting in the identification of cardiovascular disorders and therefore leading to market growth of immunoassay.

Therefore, the factors mentioned above, and the increasing awareness of people regarding early disease diagnosis in the region are some of the important factors which are thereby responsible for driving the market in North America during the forecast period.

Immunoassay Market Key Players:

Some of the key market players operating in the immunoassay market include Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation, Sysmex Corporation, Awareness Technology Inc, ZECEN Biotech Co., Quidel Corporation, among others.

Recent Developmental Activities in the Immunoassay Market:

  • In August 2023, Fapon Biotech launched its latest chemiluminescence immunoassay analyzer. The Shine i8000/9000 consists of innovative features and has an ultra-high throughput of 900 tests per hour.
  • In November 2022, Gethin Biotech introduced the new MAGICAL 6000 chemiluminescence immunoassay Analyzer at MEDICA.
  • In April 2021, Snibe, Diagnostic received CE marking for Maglumi HIV Ab/Ag Combi CLIA kit which detects HIV-1 and HIV-2 antibodies and the HIV-1 p24 antigen.

Key Takeaways from the Immunoassay Market Report Study

  • Market size analysis for current immunoassay market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/and technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global immunoassay market.
  • Various opportunities available for the other competitors in the immunoassay market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current immunoassay market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for immunoassay market growth in the coming future?

Target Audience who can be benefited from this Immunoassay Market Report Study

  • Immunoassay product providers
  • Research organizations and consulting companies
  • Immunoassay-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Immunoassay
  • Various end-users who want to know more about the immunoassay market and the latest technological developments in the Immunoassay market

Frequently Asked Questions for the Immunoassay Market:

1. What is meant by Immunoassay?

Immunoassays are bioanalytical methods that usually employ the specificity of antigen-antibody reactions to detect the target molecules in the samples. These are highly specific and sensitive and the reagents used are antibodies and purified antigens, which contribute to their great specificity.

2. What is the market for global Immunoassay?

The global Immunoassay market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Immunoassay market?

The immunoassay market is slated to witness prosperity owing to factors such as the growing prevalence of chronic diseases such as cancers, thyroid diseases, lifestyle disorders such as diabetes mellitus, and others. Additionally, there is a large patient pool suffering from various cardiovascular and autoimmune disorders globally. Further, the rising awareness of health, the growing focus on improving accuracy, affordability, portability, and usability of immunoassay for end-users are expected to result in the appreciable revenue growth of the immunoassay market during the forecast period (2024-2030).

4. Who are the key players operating in the global immunoassay market?

Some of the key market players operating in the Immunoassay market include Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation, Sysmex Corporation, Awareness Technology Inc., ZECEN Biotech Co., Quidel Corporation, among others.

5. Which region has the highest share in the global immunoassay market?

North America is expected to dominate the overall Immunoassay Market during the forecast period from 2024 to 2030. Due to the presence of a large patient pool associated with various diseases such as diabetes mellitus, and cardiovascular diseases this can be further attributed to the poor lifestyle of people. Further, the region has a very potent market for product development and launches, a high level of consumer knowledge regarding new market launches, support from the government, and the presence of local and significant market players.

Table of Contents

1. Immunoassay Market Report Introduction

2. Immunoassay Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Immunoassay Market Key Factors Analysis

  • 4.1. Immunoassay Market Drivers
    • 4.1.1. Increasing prevalence of chronic disorders such as cancers, lifestyle disorders such as diabetes mellitus, and others
    • 4.1.2. Increasing cases of infectious disorders such as HIV, hepatitis, and others
    • 4.1.3. Growing awareness among people regarding early disease diagnosis
  • 4.2. Immunoassay Market Restraints and Challenges
    • 4.2.1. Technical issues associated with immunoassay kits and instruments
    • 4.2.2. High costs and lack of skilled healthcare experts
  • 4.3. Immunoassay Market Opportunities
    • 4.3.1. Technological advancements such as enhanced product accuracy
    • 4.3.2. Increase in affordability and availability of portable and easy-to-use diagnostic equipment

5. Immunoassay Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Immunoassay Market Layout

  • 6.1. By Product
    • 6.1.1. Reagents & Kits
    • 6.1.2. Instruments
  • 6.2. By Technology
    • 6.2.1. Radioimmunoassay
    • 6.2.2. Enzyme Linked Immunoassay
    • 6.2.3. Fluoroimmunoassay
    • 6.2.4. Chemiluminescence Immunoassay
    • 6.2.5. Others
  • 6.3. By Application
    • 6.3.1. Infectious Disease Testing
    • 6.3.2. Cardiology
    • 6.3.3. Oncology
    • 6.3.4. Endocrinology
    • 6.3.5. Autoimmune Disorders
    • 6.3.6. Others
  • 6.4. By Sample
    • 6.4.1. Blood
    • 6.4.2. Urine
    • 6.4.3. Saliva
  • 6.5. By End-User
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Diagnostic Labs
    • 6.5.3. Pharmaceutical & Biotech Industries
    • 6.5.4. Others
  • 6.6. By Geography
    • 6.6.1. North America
      • 6.6.1.1. United States Immunoassay Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Immunoassay Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Immunoassay Market Size in USD million (2021-2030)
    • 6.6.2. Europe
      • 6.6.2.1. France Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Immunoassay Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific
      • 6.6.3.1. China Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.3. India Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia-Pacific Immunoassay Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW)
      • 6.6.4.1. Middle East Immunoassay Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Immunoassay Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Immunoassay Market Size in USD million (2021-2030)

7. Immunoassay Market Company and Product Profiles

  • 7.1. Beckman Coulter, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Siemens Healthcare GmbH
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. F. Hoffmann-La Roche Ltd.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Abbott Laboratories
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Thermo Fisher Scientific, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Autobio
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. PHC Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Trivitron Healthcare
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Werfen
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Danaher Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Sysmex Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. ALPCO
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Quidel Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. ZECEN Biotech Co. Ltd.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Awareness Technology
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Diatron
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Macscura Biotechnology Co.
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Guangzhou Jinde Biotech Co., Ltd.
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Medcaptain Medical Technology Co., Ltd.
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Immunoassay Market in Global (2021-2030)
  • Table 3: Immunoassay Market in Global by Product (2021-2030)
  • Table 4: Immunoassay Market in Global by Technology (2021-2030)
  • Table 5: Immunoassay Market in Global by Application (2021-2030)
  • Table 6: Immunoassay Market in Global by Sample (2021-2030)
  • Table 7: Immunoassay Market in Global by End-User (2021-2030)
  • Table 8: Immunoassay Market in Global by Geography (2021-2030)
  • Table 9: Immunoassay Market in North America (2021-2030)
  • Table 10: Immunoassay Market in North America by Country (2021-2030)
  • Table 11: Immunoassay Market in the United States (2021-2030)
  • Table 12: Immunoassay Market in Canada (2021-2030)
  • Table 13: Immunoassay Market in Mexico (2021-2030)
  • Table 14: Immunoassay Market in Europe (2021-2030)
  • Table 15: Immunoassay Market in Europe by Country (2021-2030)
  • Table 16: Immunoassay Market in France (2021-2030)
  • Table 17: Immunoassay Market in Germany (2021-2030)
  • Table 18: Immunoassay Market in the United Kingdom (2021-2030)
  • Table 19: Immunoassay Market in Italy (2021-2030)
  • Table 20: Immunoassay Market in Spain (2021-2030)
  • Table 21: Immunoassay Market in the Rest of Europe (2021-2030)
  • Table 22: Immunoassay Market in Asia-Pacific (2021-2030)
  • Table 23: Immunoassay Market in Asia-Pacific by Country (2021-2030)
  • Table 24: Immunoassay Market in China (2021-2030)
  • Table 25: Immunoassay Market in Japan (2021-2030)
  • Table 26: Immunoassay Market in India (2021-2030)
  • Table 27: Immunoassay Market in Australia (2021-2030)
  • Table 28: Immunoassay Market in South Korea (2021-2030)
  • Table 29: Immunoassay Market in Rest of Asia-Pacific (2021-2030)
  • Table 30: Immunoassay Market in the Rest of the World (2021-2030)
  • Table 31: Immunoassay Market in RoW by Region (2021-2030)
  • Table 32: Immunoassay Market in the Middle East (2021-2030)
  • Table 33: Immunoassay Market in Africa (2021-2030)
  • Table 34: Immunoassay Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Immunoassay Market in Global (2021-2030)
  • Figure 3: Immunoassay Market in Global by Product (2021-2030)
  • Figure 4: Immunoassay Market in Global by Technology (2021-2030)
  • Figure 5: Immunoassay Market in Global by Application (2021-2030)
  • Figure 6: Immunoassay Market in Global by Sample (2021-2030)
  • Figure 7: Immunoassay Market in Global by End-User (2021-2030)
  • Figure 8: Immunoassay Market in Global by Geography (2021-2030)
  • Figure 9: Immunoassay Market in North America (2021-2030)
  • Figure 10: Immunoassay Market in North America by Country (2021-2030)
  • Figure 11: Immunoassay Market in the United States (2021-2030)
  • Figure 12: Immunoassay Market in Canada (2021-2030)
  • Figure 13: Immunoassay Market in Mexico (2021-2030)
  • Figure 14: Immunoassay Market in Europe (2021-2030)
  • Figure 15: Immunoassay Market in Europe by Country (2021-2030)
  • Figure 16: Immunoassay Market in France (2021-2030)
  • Figure 17: Immunoassay Market in Germany (2021-2030)
  • Figure 18: Immunoassay Market in the United Kingdom (2021-2030)
  • Figure 19: Immunoassay Market in Italy (2021-2030)
  • Figure 20: Immunoassay Market in Spain (2021-2030)
  • Figure 21: Immunoassay Market in the Rest of Europe (2021-2030)
  • Figure 22: Immunoassay Market in Asia-Pacific (2021-2030)
  • Figure 23: Immunoassay Market in Asia-Pacific by Country (2021-2030)
  • Figure 24: Immunoassay Market in China (2021-2030)
  • Figure 25: Immunoassay Market in Japan (2021-2030)
  • Figure 26: Immunoassay Market in India (2021-2030)
  • Figure 27: Immunoassay Market in Australia (2021-2030)
  • Figure 28: Immunoassay Market in South Korea (2021-2030)
  • Figure 29: Immunoassay Market in Rest of Asia-Pacific (2021-2030)
  • Figure 30: Immunoassay Market in the Rest of the World (2021-2030)
  • Figure 31: Immunoassay Market in RoW by Region (2021-2030)
  • Figure 32: Immunoassay Market in the Middle East (2021-2030)
  • Figure 33: Immunoassay Market in Africa (2021-2030)
  • Figure 34: Immunoassay Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis